Cenobamate is used for the treatment of partial-onset seizures in adults. Its overall tolerability is acceptable, but vigilance regarding serious adverse reactions and common side effects is still necessary.

I. Serious Adverse Reactions

1. Hypersensitivity Reaction and DRESS

Drug reaction with eosinophilia and systemic symptoms (DRESS) may occur.

Manifested as fever, rash, lymphadenopathy, and facial swelling, which can involve organs such as the liver and kidneys.

The risk is higher with rapid dose escalation; discontinue the medication immediately and seek medical attention if suspected.

2. QT Shortening

Cenobamate can cause dose-dependent QT interval shortening.

Contraindicated in patients with familial short QT syndrome.

Use with caution when combined with other drugs that shorten the QT interval.

3. Suicidal Ideation and Behavior

Antiepileptic drugs may increase the risk of suicidal ideation or behavior.

Monitor for worsening depression, abnormal mood, or behavioral changes.

Report related symptoms to a doctor immediately if they appear.

4. Nervous System Reactions

Commonly includes somnolence, fatigue, dizziness, gait disturbance, and coordination impairment.

May affect attention, memory, and mental clarity.

The risk is higher during the initial treatment period, but can occur at any time.

5. Withdrawal Risk

Sudden discontinuation can increase seizure frequency and even lead to status epilepticus.

Generally, it should be gradually tapered over at least 2 weeks.

II. Common Adverse Reactions

1. Nervous System Symptoms

Somnolence, dizziness, and fatigue are the most common.

Some patients experience headache, balance disorders, and ataxia.

Most are mild to moderate and may diminish as treatment continues.

2. Vision-Related Symptoms

Diplopia, blurred vision, or visual impairment may occur.

A small number of patients discontinued treatment due to visual changes.

3. Psychiatric Symptoms

Confusion, irritability, or euphoria may occur.

A small number of patients reported suicidal ideation.

4. Gastrointestinal Symptoms

Nausea, constipation, diarrhea, vomiting, and dry mouth can be observed.

Some patients experience decreased appetite and weight loss.

5. Other Symptoms

Back pain, asthenia, dyspnea, or rash may occur.

Rarely, the incidence of appendicitis is higher than in the general population.

III. Laboratory Abnormalities and Medication Monitoring

1. Liver Enzyme Elevation

Some patients experience elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST).

In very few patients, ALT elevations exceed 3 times the upper limit of normal.

Liver function changes should be monitored during treatment.

2. Blood Potassium Elevation

Some patients experience elevated serum potassium exceeding 5 mEq/L.

Most are mild, but regular monitoring is required.

3. Weight Changes

Some patients experience weight loss.

Attention should be paid to appetite and nutritional status.

4. Monitoring Recommendations

Regularly evaluate mood, behavior, and neurological symptoms.

Pay attention to early signs of hypersensitivity reactions such as rash and fever.

Be mindful of drug interactions during combination therapy, and adjust doses when necessary.